Developer docs
API playgroundTry for free, no card

Search company profiles

Advent Access

Full company profile

uuid0005551

Namestring
Advent Access
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Advent Access is a Singapore-based medical technology startup founded in 2015 by CEO Peh Ruey Feng. The company operates in the medical device sector, with its name suggesting a focus on vascular or medical access technology, though no specific product descriptions, technical specifications, or clinical applications are disclosed in the available data. Advent Access raised approximately $1.92 million in a December 2017 funding round led by Advanced MedTech, which represents the only confirmed capital event in the company's history.

The company has maintained a headcount of 1-10 employees since founding and has not disclosed any subsequent funding rounds, partnerships, product launches, or commercial milestones. The company's primary web domain, adventaccess.com, is currently listed for sale on HugeDomains for $13,595, which is a strong indicator that the company has either ceased operations, allowed its domain registration to lapse, or is attempting to monetize a non-operational digital asset. No revenue figures, customer relationships, distribution channels, pricing models, or business model details are available in the provided data.

Given the absence of verifiable operational signals since 2017 and the dormant status of its primary web property, any assessment of Advent Access's current business activity is constrained. The input data does not provide evidence of active product development, clinical trials, regulatory approvals, customer engagements, or revenue generation. This analysis should be treated as preliminary, and further primary-source verification would be required before drawing operational or investment conclusions.

Short descriptiontext

Advent Access is a Singapore-based medical technology startup founded in 2015 by Peh Ruey Feng, focused on vascular or medical access device development. The company raised $1.92M from Advanced MedTech in 2017 and currently shows signs of operational dormancy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
medical devices, medical technology, vascular access, healthcare devices, clinical innovation
Industry1 code
1Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
CodeHLACAPABPrimaryYes
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Advent Access is a Singapore-based medical technology startup founded in 2015 that develops medical device products. Specific product details, clinical indications, and technical specifications are not disclosed in the publicly available source material.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The source data is from a domain name marketplace listing (HugeDomains.com) for the domain AdventAccess.com, which is for sale. No product or service information for Advent Access as a company is available in this source. The page is a domain parking/listing page and does not represent the actual Advent Access company's offerings, products, or technology.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers8 records
TypeBroad incumbent
Description

Teleflex is a major vascular access and interventional product company with strong presence in dialysis catheter and AV access adjacencies. Comparable as an incumbent whose core franchise overlaps with the vascular access category Advent Access addresses.

TypeBroad incumbent
Description

Medtronic operates across cardiovascular, peripheral vascular, and renal care, including products interfacing with dialysis vascular access. It is comparable as a broad medtech incumbent whose portfolio overlaps with the vascular access problem space Advent Access is pursuing.

TypeEmerging player
Description

Outset Medical developed the Tablo hemodialysis system, targeting simplification of dialysis care delivery including vascular access workflows. Comparable as an emerging medtech company attacking the same dialysis/end-stage renal disease customer with a hardware-enabled approach.

TypeBroad incumbent
Description

Fresenius is the world's largest dialysis services and product company, with major exposure to vascular access consumables and devices. Comparable as the dominant incumbent shaping the customer relationships and procurement standards that any vascular access innovator must navigate.

TypeBroad incumbent
Description

Smiths Medical supplies vascular access, infusion, and dialysis-related devices globally. It is comparable as an incumbent operating in similar product categories and end customers as Advent Access.

TypeBroad incumbent
Description

BD is the dominant global player in vascular access devices, including dialysis catheters and AV fistula products. It is broadly comparable as the entrenched incumbent in the same end-market (vascular access for hemodialysis) that Advent Access targets, providing the benchmark the startup must beat on incumbency, sales reach, and product breadth.

TypeEmerging player
Description

Avenu Medical developed percutaneous fistula creation technology for dialysis access, directly addressing AV fistula creation — the same core clinical problem Advent Access targets. Highly comparable as a near-direct emerging player in the dialysis vascular access device category.

TypeEmerging player
Description

Venclose developed a catheter-based system for venous ablation and vascular procedures. Comparable as a small, venture-backed medical device company pursuing a catheter/procedure-based approach to vascular disease in adjacent anatomical territory.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Advent Access

Medical Devicesadventaccess.com

Advent Access is a Singapore-based medical technology startup founded in 2015 by Peh Ruey Feng, focused on vascular or medical access device development. The company raised $1.92M from Advanced MedTech in 2017 and currently shows signs of operational dormancy.

What Advent Access does

Advent Access is a Singapore-based medical technology startup founded in 2015 by CEO Peh Ruey Feng. The company operates in the medical device sector, with its name suggesting a focus on vascular or medical access technology, though no specific product descriptions, technical specifications, or clinical applications are disclosed in the available data. Advent Access raised approximately $1.92 million in a December 2017 funding round led by Advanced MedTech, which represents the only confirmed capital event in the company's history.

The company has maintained a headcount of 1-10 employees since founding and has not disclosed any subsequent funding rounds, partnerships, product launches, or commercial milestones. The company's primary web domain, adventaccess.com, is currently listed for sale on HugeDomains for $13,595, which is a strong indicator that the company has either ceased operations, allowed its domain registration to lapse, or is attempting to monetize a non-operational digital asset. No revenue figures, customer relationships, distribution channels, pricing models, or business model details are available in the provided data.

Given the absence of verifiable operational signals since 2017 and the dormant status of its primary web property, any assessment of Advent Access's current business activity is constrained. The input data does not provide evidence of active product development, clinical trials, regulatory approvals, customer engagements, or revenue generation. This analysis should be treated as preliminary, and further primary-source verification would be required before drawing operational or investment conclusions.

Advent Access firmographics

Firmographics
Name
Advent Access
Website
https://adventaccess.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Advent Access is a Singapore-based medical technology startup founded in 2015 by Peh Ruey Feng, focused on vascular or medical access device development. The company raised $1.92M from Advanced MedTech in 2017 and currently shows signs of operational dormancy.
Ownership category
akta.pro rank

Advent Access industry classification

Industry
Product category
Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

  • Medical devices
  • Medical technology
  • Vascular access
  • Healthcare devices
  • Clinical innovation

Where Advent Access is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Markets served

Advent Access business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Advent Access product offering

Product offering

Core offering

Advent Access is a Singapore-based medical technology startup founded in 2015 that develops medical device products. Specific product details, clinical indications, and technical specifications are not disclosed in the publicly available source material.

Product overview

The source data is from a domain name marketplace listing (HugeDomains.com) for the domain AdventAccess.com, which is for sale. No product or service information for Advent Access as a company is available in this source. The page is a domain parking/listing page and does not represent the actual Advent Access company's offerings, products, or technology.

Differentiator

Problem solved

Functional benefit

Companies that use Advent Access

Customer profile

Ideal customer profiles1 record

Advent Access technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Advent Access partnerships and signals

Strategic signal

Recent moves3 records

Advent Access competitors and assessment

Company assessment

Broad incumbents

  • Teleflex: Teleflex is a major vascular access and interventional product company with strong presence in dialysis catheter and AV access adjacencies. Comparable as an incumbent whose core franchise overlaps with the vascular access category Advent Access addresses.
  • Medtronic: Medtronic operates across cardiovascular, peripheral vascular, and renal care, including products interfacing with dialysis vascular access. It is comparable as a broad medtech incumbent whose portfolio overlaps with the vascular access problem space Advent Access is pursuing.
  • Fresenius Medical Care: Fresenius is the world's largest dialysis services and product company, with major exposure to vascular access consumables and devices. Comparable as the dominant incumbent shaping the customer relationships and procurement standards that any vascular access innovator must navigate.
  • Smiths Medical: Smiths Medical supplies vascular access, infusion, and dialysis-related devices globally. It is comparable as an incumbent operating in similar product categories and end customers as Advent Access.
  • Becton, Dickinson and Company (BD): BD is the dominant global player in vascular access devices, including dialysis catheters and AV fistula products. It is broadly comparable as the entrenched incumbent in the same end-market (vascular access for hemodialysis) that Advent Access targets, providing the benchmark the startup must beat on incumbency, sales reach, and product breadth.

Emerging players

  • Outset Medical: Outset Medical developed the Tablo hemodialysis system, targeting simplification of dialysis care delivery including vascular access workflows. Comparable as an emerging medtech company attacking the same dialysis/end-stage renal disease customer with a hardware-enabled approach.
  • Avenu Medical: Avenu Medical developed percutaneous fistula creation technology for dialysis access, directly addressing AV fistula creation — the same core clinical problem Advent Access targets. Highly comparable as a near-direct emerging player in the dialysis vascular access device category.
  • Venclose: Venclose developed a catheter-based system for venous ablation and vascular procedures. Comparable as a small, venture-backed medical device company pursuing a catheter/procedure-based approach to vascular disease in adjacent anatomical territory.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Advent Access social profiles

Digital presence

Advent Access financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Advent Access leadership team

Management profile

Number of profiles

Profiles1 record

Advent Access funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Advent Access M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advent Access

What does Advent Access do?

Advent Access is a Singapore-based medical technology startup founded in 2015 that develops medical device products. Specific product details, clinical indications, and technical specifications are not disclosed in the publicly available source material.

When was Advent Access founded?

Advent Access was founded in 2015. It employs 1 to 10 people.

Where is Advent Access based?

Advent Access is headquartered in Singapore, Singapore, in the Asia region.

Who are Advent Access's main competitors?

Broad incumbents on record are Teleflex, Medtronic, Fresenius Medical Care, Smiths Medical and Becton, Dickinson and Company (BD). Emerging players are Outset Medical, Avenu Medical and Venclose.

Does Advent Access have an API?

No public API is recorded for Advent Access.

What industry is Advent Access in?

Advent Access's product category is Medical Devices. Its primary akta.pro industry code is HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals